Clinical Trial

Impact of Age-related Macular Degeneration on Daily Living Activitie

Study acronym: AMDAY
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The complex and variable course of age-related diseases makes it all the more necessary to carry out personalised, reasoning-based examinations to improve the personalised assessment and management of AMD. However, functional assessment of AMD is most often based solely on visual acuity, and classifications of AMD are based solely on structural markers. There is therefore a need to improve the detection and functional assessment of this vision-threatening eye disease, by complementing and extending the standard assessments of clinical outcomes (COA)
Trial Details
NCT Number NCT06333873
Lead Sponsor Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Conditions Age-Related Macular Degeneration
Enrollment 120 participants
Start Date 2024-06
Primary Completion 2029-06 (estimated)
Study Completion 2029-06 (estimated)
Updated on ClinicalTrials.gov 2024-03-27